A preprint described by Nature monitored protein kinase A activity in the brains of mice in real time during sleep and wakefulness. The protein-phosphorylation signal remained high during wakefulness and progressively decreased during sleep.

Brief reactivations interrupted that decline with new peaks. By combining sleep duration and fragmentation, the signal predicted the instantaneous probability of waking more accurately than time since sleep onset alone.

For nutraceutical research, the immediate value is methodological. If an analogous mechanism were validated in humans, it could complement questionnaires, actigraphy and polysomnography when assessing interventions designed for sleep and recovery.

The distance from practical application remains considerable: the work concerns mouse models, has not undergone peer review and does not show that the signal can be measured non-invasively or effectively modified by an ingredient.

Why it matters

Objective biomarkers of duration and fragmentation could eventually improve endpoint selection in studies of sleep, recovery and nutraceutical ingredients.

Evidence limit

This is a preclinical result released as a preprint and discussed by Nature, not a peer-reviewed study or a biomarker validated in humans.

Editorial note. This content is intended for industry professionals. It does not constitute medical advice, therapeutic guidance or regulatory advice. Read our editorial method.

Read the original source · Nature ↗